Proactive Investors - Run By Investors For Investors

'It's never been so busy and exciting', says Alliance Pharma PLC CEO

Alliance Pharma plc (LON:APH) said revenues had more than doubled and trading profits for the year to the end of December were in line with City forecasts as it provided investors with a progress report.

The speciality pharma company said it expects sales to be £97.5mln - up from £48.3mln a year earlier.

CEO John Dawson tells Proactive: 'It's never been so busy and exciting - the prospects are really good.''

 
View full APH profile View Profile

Alliance Pharma PLC Timeline

Newswire
January 21 2019
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use